Dr. Daniel Drucker is a clinician-scientist who develops treatments for diabetes, obesity, and intestinal disorders He studies peptide hormones produced in the pancreas, gastrointestinal tract and brain. His lab has carried out basic research leading to two new treatments for type 2 diabetes and one new therapy for short bowel syndrome He holds the Canada Research Chair in Regulatory Peptides and the Banting and best Diabetes Centre-Novo Nordisk chair in Incretin biology